Enfortumab-VedotinVery useful and its efficacy was found to be the best, maybe in the next years it'll become the first line of treatment, but for now the approvational studies suggests to use it after immunotherapy |
Map: A patient with Urothelial cancer (1038)
|
||
|
Review your pathway |
